Institutional Biosafety

The National Institutes of Health (NIH) and the Office of Biotechnology Activities require that universities maintain the highest level of scientific integrity and community safety in the review of research involving genetic engineering, the splicing together of DNA from different organisms. Strict rules have been established regarding types of experimentation allowable and under what circumstances different classes of experiments can be conducted. The NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) detail safety practices and containment procedures for basic and clinical research involving recombinant or synthetic nucleic acid molecules, including the creation and use of organisms and viruses containing recombinant or synthetic nucleic acid molecules.

The Binghamton University Institutional Biosafety Committee (IBC) reviews all such research.  The foundation of all IBC reviews is in adherence to the recommendation within the guidelines provided by the NIH. The IBC will follow and abide by those recommendations and reserves the right to impose tighter restrictions to ensure the safety of PIs, research assistants, the campus, and the community. 

You can find the Institutional Biosafety Committee Registration form here.

You can find the Select Agents, Pathogens and Toxins Notification of Possession form here.

Should you need information about this committee, contact: David Davies, committee chair, at


Guidelines and Resources

NIH Guidelines for Research Involving Recombinant DNA Molecules

NIH Covered Classes (III)

Regulated Medical Waste - Guidelines for the Handling and Disposal 

Last Updated: 10/6/16